Lv3
390 积分 2021-03-03 加入
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
9小时前
待确认
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
1天前
已完结
The research landscape and evolutionary trends of robot-assisted orthopedic telesurgery: a bibliometric and visualized analysis
11天前
已完结
Tertiary lymphoid structures in anticancer immunity
21天前
已完结
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
21天前
已完结
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside
21天前
已完结
Galectin-9-driven immunosuppressive macrophage population shapes the lymph node metastatic microenvironment
22天前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
25天前
已完结
Molecular characterization and antibacterial ability of galectin-3 and galectin-9 in Onychostoma macrolepis
1个月前
已完结
Vabametkib Treatment in Refractory Glioblastoma: A Case Report
1个月前
已完结
皖公网安备34019202002308
